Ampio Pharmaceuticals (NYSE:AMPE) Earns Sell Rating from Analysts at StockNews.com

Stock analysts at StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a report issued on Saturday. The brokerage set a “sell” rating on the stock.

Ampio Pharmaceuticals Stock Performance

NYSE AMPE opened at $0.00 on Friday. Ampio Pharmaceuticals has a 12-month low of $0.00 and a 12-month high of $1.99. The firm’s fifty day simple moving average is $0.01 and its two-hundred day simple moving average is $0.01. The firm has a market capitalization of $2,383.50, a P/E ratio of 0.00 and a beta of 3.77.

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.